Centerstone Health Services, Inc. | |
720 N Marr Rd Ste A Columbus IN 47201-6660 | |
(812) 314-3400 | |
(812) 376-4875 |
Full Name | Centerstone Health Services, Inc. |
---|---|
Speciality | Clinic/Center |
Location | 720 N Marr Rd Ste A, Columbus, Indiana |
Authorized Official Name and Position | Jenny Harrison (CEO) |
Authorized Official Contact | 8123508249 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Centerstone Health Services, Inc. 645 S Rogers St Ste A Bloomington IN 47403-2353 Ph: (812) 339-1691 | Centerstone Health Services, Inc. 720 N Marr Rd Ste A Columbus IN 47201-6660 Ph: (812) 314-3400 |
NPI Number | 1114553948 |
---|---|
Provider Enumeration Date | 03/12/2020 |
Last Update Date | 03/11/2024 |
Medicare PECOS PAC ID | 1850497173 |
---|---|
Medicare Enrollment ID | O20210721001332 |
News Archive
Adult male monkeys exposed to cocaine while in the womb have poor impulse control and may be more vulnerable to drug abuse than female monkeys, even a decade or more after the exposure, according to a new study by researchers at Wake Forest University School of Medicine. The findings could lead to a better understanding of human drug abuse.
A comprehensive care program that involves a team of specialists from multiple medical disciplines for treating injuries sustained from falls in older adults could help reduce hospital readmissions, according to researchers at Henry Ford Hospital in Detroit.
In one of the pioneering genetic studies of acne, it has been seen that the condition that affects millions of teenagers and adults could have a genetic basis. This genetic study can also pave the way for new and accurate treatment for acne promise researchers. The study results are published in the latest issue of the journal Nature Communications.
Teresa Woodruff, the Thomas J. Watkins Professor of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, received the prestigious Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring at the White House from President Barack Obama Monday, Dec. 12.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1114553948 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Adult male monkeys exposed to cocaine while in the womb have poor impulse control and may be more vulnerable to drug abuse than female monkeys, even a decade or more after the exposure, according to a new study by researchers at Wake Forest University School of Medicine. The findings could lead to a better understanding of human drug abuse.
A comprehensive care program that involves a team of specialists from multiple medical disciplines for treating injuries sustained from falls in older adults could help reduce hospital readmissions, according to researchers at Henry Ford Hospital in Detroit.
In one of the pioneering genetic studies of acne, it has been seen that the condition that affects millions of teenagers and adults could have a genetic basis. This genetic study can also pave the way for new and accurate treatment for acne promise researchers. The study results are published in the latest issue of the journal Nature Communications.
Teresa Woodruff, the Thomas J. Watkins Professor of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, received the prestigious Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring at the White House from President Barack Obama Monday, Dec. 12.
Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.
› Verified 3 days ago
Promptmed Urgent Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2502 25th St, Columbus, IN 47201 Phone: 812-372-8883 Fax: 812-372-8964 | |
Columbus Regional Health Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2325 18th St, Suite 130, Columbus, IN 47201 Phone: 812-379-2020 | |
Columbus Regional Health Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2326 18th St, Suite 120, Columbus, IN 47201 Phone: 812-372-1570 | |
Columbus Regional Health Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2326 18th St, Suite 210, Columbus, IN 47201 Phone: 812-372-8426 | |
Ourhealth Physicians Group, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6125 Inwood Dr, Columbus, IN 47201 Phone: 866-434-3255 | |
Cummins Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 806 Jackson St, Columbus, IN 47201 Phone: 812-748-3412 Fax: 812-748-3413 |